Skip Navigation | En Español

Skip secondary menu

Disorders A - Z

News From NINDS

Funding Information

NINDS Funding
   Strategy- FY 2013
2012 NINDS Funding
   Outcomes
Funding Opportunities
Grant Mechanisms
Training & Career
   Awards
Contracts Management
Review Committees
Funding News
Offices and Programs
Small Business

Research Programs

Training & Career Awards

Enhancing Diversity

Email this page

Print-friendly version

Contact NINDS

Adobe Reader

Microsoft Word Viewer

Translational Research

The mission of the Office of Translational Research is to facilitate the preclinical discovery and development of new therapeutic interventions for neurological disorders by:

Supporting preclinical development from the discovery of candidate therapeutics to Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications to the FDA
Support translational research projects and networks
Supporting the design, implementation, and management of research infrastructure

More Information on the Translational Research program area.

Funding Initiatives in this category:

Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01)
Release Date: 2013-04-25, Contact: David Jett, Ph.D., [ (U01) PAR-13-208 ]

NINDS Cooperative Program in Translational Research (U01)
Release Date: 2012-11-19, Contact: Linda McGavern, Ph.D., [ (U01) PAR13-022 ]

NINDS Exploratory/Developmental Projects in Translational Research (R21)
Release Date: 2012-11-19, Contact: Christina Vert, M.S., [ (R21) PAR-13-023 ]

Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R01)
Release Date: 2011-12-13, Contact: David Jett, Ph.D., [ (R01) PAR-12-058 ]

Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01)
Release Date: 2011-12-13, Contact: Rebecca Farkas, Ph.D., [ (R01) PAR-12-060 ]

Development of Appropriate Pediatric Formulations and Drug Delivery Systems SBIR (R43)
Release Date: 2011-08-11, Contact: Stephanie Fertig, MBA, [ (R43) PAR-11-304 ]

Development of Appropriate Pediatric Formulations and Drug Delivery Systems STTR (R41)
Release Date: 2011-08-11, Contact: Stephanie Fertig, MBA, [ (R41) PAR-11-305 ]

Improving the Quality of NINDS-Supported Preclinical and Clinical Research through Rigorous Study Design and Transparent Reporting
Release Date: 2011-08-10, Contact: Shai Silberberg, Ph.D., [ NOT-NS-11-023 ]

NIH Offers SBIR Niche Assessment Program to Phase I Awardees
Release Date: 2011-07-15, Contact: NINDS Funding Coordinator, [ NOT-OD-11-094 ]

Lab to Marketplace: Tools for Brain and Behavioral Research (SBIR [R43/R44])
Release Date: 2011-02-25, Contact: Stephanie Fertig, MBA, [ (R43/R44) PA-11-134 ]

Continued Development and Maintenance of Software (R01)
Release Date: 2010-11-12, Contact: Yuan Liu, Ph.D., [ (R01) PAR-11-028 ]

Notice of Intent to Publish a Program Announcement for Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21)
Release Date: 2009-09-22, Contact: David Jett, Ph.D., [ (R21) NOT-NS-09-018 ]

Status of Applications and Awards under the New NIH Guidelines for Human Stem Cell Research
Release Date: 2009-07-15, Contact: NINDS Funding Coordinator, [ NOT-OD-09-123 ]

The SMA Project: A Collaborative Program to Accelerate Therapeutics Development for Spinal Muscular Atrophy (SMA)
Release Date: 2004-03-18, Contact: Jill Heemskerk, Ph.D., [ NOT-SMA-Project ]
Also See: http://www.smaproject.org